(877)540-0933 support@enabledoc.com
| No Comments

New ICD10 Codes for 20221 starting October 1, 2021:

A79.82  Anaplasmosis [A. phagocytophilum]

C56.3  Malignant neoplasm of bilateral ovaries

C79.63  Secondary malignant neoplasm of bilateral ovaries

C84.7A  Anaplastic large cell lymphoma, ALK-negative, breast

D55.2  Anemia due to disorders of glycolytic enzymes

D55.21  Anemia due to pyruvate kinase deficiency

D55.29  Anemia due to other disorders of glycolytic enzymes

D75.83  Thrombocytosis

D75.838  Other thrombocytosis

D75.839  Thrombocytosis, unspecified

D89.44  Hereditary alpha tryptasemia

E75.244  Niemann-Pick disease type A/B

F32.A  Depression, unspecified

F78  Other intellectual disabilities

F78.A  Other genetic related intellectual disabilities

F78.A1  SYNGAP1-related intellectual disability

F78.A9  Other genetic related intellectual disability

G04.82  Acute flaccid myelitis

G44.86  Cervicogenic headache

G92  Toxic encephalopathy

G92.0  Immune effector cell-associated neurotoxicity syndrome

G92.00  Immune effector cell-associated neurotoxicity syndrome, grade unspecified

G92.01  Immune effector cell-associated neurotoxicity syndrome, grade 1

G92.02  Immune effector cell-associated neurotoxicity syndrome, grade 2

G92.03  Immune effector cell-associated neurotoxicity syndrome, grade 3

G92.04  Immune effector cell-associated neurotoxicity syndrome, grade 4

G92.05  Immune effector cell-associated neurotoxicity syndrome, grade 5

G92.8  Other toxic encephalopathy

G92.9  Unspecified toxic encephalopathy

I5A  Non-ischemic myocardial injury (non-traumatic)

K22.8  Other specified diseases of esophagus

K22.81  Esophageal polyp

K22.82  Esophagogastric junction polyp

K22.89  Other specified disease of esophagus

K31.A  Gastric intestinal metaplasia

K31.A0  Gastric intestinal metaplasia, unspecified

K31.A1  Gastric intestinal metaplasia without dysplasia

K31.A11  Gastric intestinal metaplasia without dysplasia, involving the antrum

K31.A12  Gastric intestinal metaplasia without dysplasia, involving the body (corpus)

K31.A13  Gastric intestinal metaplasia without dysplasia, involving the fundus

K31.A14  Gastric intestinal metaplasia without dysplasia, involving the cardia

K31.A15  Gastric intestinal metaplasia without dysplasia, involving multiple sites

K31.A19  Gastric intestinal metaplasia without dysplasia, unspecified site

K31.A2  Gastric intestinal metaplasia with dysplasia

K31.A21  Gastric intestinal metaplasia with low grade dysplasia

K31.A22  Gastric intestinal metaplasia with high grade dysplasia

K31.A29  Gastric intestinal metaplasia with dysplasia, unspecified

L24.A  Irritant contact dermatitis due to friction or contact with body fluids

L24.A0  Irritant contact dermatitis due to friction or contact with body fluids, unspecified

L24.A1  Irritant contact dermatitis due to saliva

L24.A2  Irritant contact dermatitis due to fecal, urinary or dual incontinence

L24.A9  Irritant contact dermatitis due friction or contact with other specified body fluids

L24.B  Irritant contact dermatitis related to stoma or fistula

L24.B0  Irritant contact dermatitis related to unspecified stoma or fistula

L24.B1  Irritant contact dermatitis related to digestive stoma or fistula

L24.B2  Irritant contact dermatitis related to respiratory stoma or fistula

L24.B3  Irritant contact dermatitis related to fecal or urinary stoma or fistula

M31.1  Thrombotic microangiopathy

M31.10  Thrombotic microangiopathy, unspecified

M31.11  Hematopoietic stem cell transplantation-associated thrombotic microangiopathy [HSCT-TMA]

M31.19  Other thrombotic microangiopathy

M35.05  Sjögren syndrome with inflammatory arthritis

M35.06  Sjögren syndrome with peripheral nervous system involvement

M35.07  Sjögren syndrome with central nervous system involvement

M35.08  Sjögren syndrome with gastrointestinal involvement

M35.0A  Sjögren syndrome with glomerular disease

M35.0B  Sjögren syndrome with vasculitis

M35.0C  Sjögren syndrome with dental involvement

M45.A  Non-radiographic axial spondyloarthritis

M45.A0  Non-radiographic axial spondyloarthritis of unspecified sites in spine

M45.A1  Non-radiographic axial spondyloarthritis of occipito-atlanto-axial region

M45.A2  Non-radiographic axial spondyloarthritis of cervical region

M45.A3  Non-radiographic axial spondyloarthritis of cervicothoracic region

M45.A4  Non-radiographic axial spondyloarthritis of thoracic region

M45.A5  Non-radiographic axial spondyloarthritis of thoracolumbar region

M45.A6  Non-radiographic axial spondyloarthritis of lumbar region

M45.A7  Non-radiographic axial spondyloarthritis of lumbosacral region

M45.A8  Non-radiographic axial spondyloarthritis of sacral and sacrococcygeal region

M45.AB  Non-radiographic axial spondyloarthritis of multiple sites in spine

M54.5  Low back pain

M54.50  Low back pain, unspecified

M54.51  Vertebrogenic low back pain

M54.59  Other low back pain

P00.82  Newborn affected by (positive) maternal group B streptococcus (GBS) colonization

P09  Abnormal findings on neonatal screening

P09.1  Abnormal findings on neonatal screening for inborn errors of metabolism

P09.2  Abnormal findings on neonatal screening for congenital endocrine disease

P09.3  Abnormal findings on neonatal screening for congenital hematologic disorders

P09.4  Abnormal findings on neonatal screening for cystic fibrosis

P09.5  Abnormal findings on neonatal screening for critical congenital heart disease

P09.6  Abnormal findings on neonatal screening for neonatal hearing loss

P09.8  Other abnormal findings on neonatal screening

P09.9  Abnormal findings on neonatal screening, unspecified

R05  Cough

R05.1  Acute cough

R05.2  Subacute cough

R05.3  Chronic cough

R05.4  Cough syncope

R05.8  Other specified cough

R05.9  Cough, unspecified

R35.8  Other polyuria

R35.81  Nocturnal polyuria

R35.89  Other polyuria

R45.88  Nonsuicidal self-harm

R63.3  Feeding difficulties

R63.30  Feeding difficulties, unspecified

R63.31  Pediatric feeding disorder, acute

R63.32  Pediatric feeding disorder, chronic

R63.39  Other feeding difficulties

R79.83  Abnormal findings of blood amino-acid level

S06.A  Traumatic brain compression and herniation

S06.A0  Traumatic brain compression without herniation

S06.A0XA  Traumatic brain compression without herniation, initial encounter

S06.A0XD  Traumatic brain compression without herniation, subsequent encounter

S06.A0XS  Traumatic brain compression without herniation, sequela

S06.A1  Traumatic brain compression with herniation

S06.A1XA  Traumatic brain compression with herniation, initial encounter

S06.A1XD  Traumatic brain compression with herniation, subsequent encounter

S06.A1XS  Traumatic brain compression with herniation, sequela

T40.71  Poisoning by, adverse effect of and underdosing of cannabis (derivatives)

T40.711  Poisoning by cannabis, accidental (unintentional)

T40.711A  Poisoning by cannabis, accidental (unintentional), initial encounter

T40.711D  Poisoning by cannabis, accidental (unintentional), subsequent encounter

T40.711S  Poisoning by cannabis, accidental (unintentional), sequela

T40.712  Poisoning by cannabis, intentional self-harm

T40.712A  Poisoning by cannabis, intentional self-harm, initial encounter

T40.712D  Poisoning by cannabis, intentional self-harm, subsequent encounter

T40.712S  Poisoning by cannabis, intentional self-harm, sequela

T40.713  Poisoning by cannabis, assault

T40.713A  Poisoning by cannabis, assault, initial encounter

T40.713D  Poisoning by cannabis, assault, subsequent encounter

T40.713S  Poisoning by cannabis, assault, sequela

T40.714  Poisoning by cannabis, undetermined

T40.714A  Poisoning by cannabis, undetermined, initial encounter

T40.714D  Poisoning by cannabis, undetermined, subsequent encounter

T40.714S  Poisoning by cannabis, undetermined, sequela

T40.715  Adverse effect of cannabis

T40.715A  Adverse effect of cannabis, initial encounter

T40.715D  Adverse effect of cannabis, subsequent encounter

T40.715S  Adverse effect of cannabis, sequela

T40.716  Underdosing of cannabis

T40.716A  Underdosing of cannabis, initial encounter

T40.716D  Underdosing of cannabis, subsequent encounter

T40.716S  Underdosing of cannabis, sequela

T40.72  Poisoning by, adverse effect of and underdosing of synthetic cannabinoids

T40.721  Poisoning by synthetic cannabinoids, accidental (unintentional)

T40.721A  Poisoning by synthetic cannabinoids, accidental (unintentional), initial encounter

T40.721D  Poisoning by synthetic cannabinoids, accidental (unintentional), subsequent encounter

T40.721S  Poisoning by synthetic cannabinoids, accidental (unintentional), sequela

T40.722  Poisoning by synthetic cannabinoids, intentional self-harm

T40.722A  Poisoning by synthetic cannabinoids, intentional self-harm, initial encounter

T40.722D  Poisoning by synthetic cannabinoids, intentional self-harm, subsequent encounter

T40.722S  Poisoning by synthetic cannabinoids, intentional self-harm, sequela

T40.723  Poisoning by synthetic cannabinoids, assault

T40.723A  Poisoning by synthetic cannabinoids, assault, initial encounter

T40.723D  Poisoning by synthetic cannabinoids, assault, subsequent encounter

T40.723S  Poisoning by synthetic cannabinoids, assault, sequela

T40.724  Poisoning by synthetic cannabinoids, undetermined

T40.724A  Poisoning by synthetic cannabinoids, undetermined, initial encounter

T40.724D  Poisoning by synthetic cannabinoids, undetermined, subsequent encounter

T40.724S  Poisoning by synthetic cannabinoids, undetermined, sequela

T40.725  Adverse effect of synthetic cannabinoids

T40.725A  Adverse effect of synthetic cannabinoids, initial encounter

T40.725D  Adverse effect of synthetic cannabinoids, subsequent encounter

T40.725S  Adverse effect of synthetic cannabinoids, sequela

T40.726  Underdosing of synthetic cannabinoids

T40.726A  Underdosing of synthetic cannabinoids, initial encounter

T40.726D  Underdosing of synthetic cannabinoids, subsequent encounter

T40.726S  Underdosing of synthetic cannabinoids, sequela

T80.82  Complication of immune effector cellular therapy

T80.82XA  Complication of immune effector cellular therapy, initial encounter

T80.82XD  Complication of immune effector cellular therapy, subsequent encounter

T80.82XS  Complication of immune effector cellular therapy, sequela

U09  Post COVID-19 condition

U09.9  Post COVID-19 condition, unspecified

Y35.899  Legal intervention involving other specified means, unspecified person injured

Y35.899A  Legal intervention involving other specified means, unspecified person injured, initial encounter

Y35.899D  Legal intervention involving other specified means, unspecified person injured, subsequent encounter

Y35.899S  Legal intervention involving other specified means, unspecified person injured, sequela

Z55.5  Less than a high school diploma

Z58  Problems related to physical environment

Z58.6  Inadequate drinking-water supply

Z59.0  Homelessness

Z59.00  Homelessness unspecified

Z59.01  Sheltered homelessness

Z59.02  Unsheltered homelessness

Z59.4  Lack of adequate food

Z59.41  Food insecurity

Z59.48  Other specified lack of adequate food

Z59.8  Other problems related to housing and economic circumstances

Z59.81  Housing instability, housed

Z59.811  Housing instability, housed, with risk of homelessness

Z59.812  Housing instability, housed, homelessness in past 12 months

Z59.819  Housing instability, housed unspecified

Z59.89  Other problems related to housing and economic circumstances

Z71.85  Encounter for immunization safety counseling

Z91.014  Allergy to mammalian meats

Z91.5  Personal history of self-harm

Z91.51  Personal history of suicidal behavior

Z91.52  Personal history of nonsuicidal self-harm

Z92.85  Personal history of cellular therapy

Z92.850  Personal history of Chimeric Antigen Receptor T-cell therapy

Z92.858  Personal history of other cellular therapy

Z92.859  Personal history of cellular therapy, unspecified

Z92.86  Personal history of gene therapy

Total Reads: 155
Categories: Blog

Leave a Reply